Clinical Trials Directory

Trials / Completed

CompletedNCT04672902

Treatment of Mirizzi Syndrome

Single-operator Cholangioscopy and Electrohydraulic Lithotripsy for the Treatment of Mirizzi Syndrome: A Case Series

Status
Completed
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
Tecnologico de Monterrey · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Mirizzi syndrome is an infrequent complication of long-standing cholelithiasis. Extrinsic compression of the common hepatic duct is usually caused by an impacted stone in Hartmann's pouch or cystic duct resulting in the development of cholecystobiliary fistula. This syndrome is classified based on the presence and severity of cholecystobiliary fistula. Mirizzi syndrome is challenging to diagnose preoperatively and may require complex biliary surgical procedures for resolution. Endoscopic treatment is a safe alternative with a high success rate. Single-operator cholangioscopy combined with lithotripsy has been shown to have a 90-100% success rate in the treatment of biliary stones. Herein, A single center experience treating Mirizzi syndrome with single-operator cholangioscopy guided electrohydraulic lithotripsy is presented. Difficult management of Mirizzi syndrome has led to research of new treatment options to minimize the risk of high rate complications. Single-operator cholangioscopy in combination with laser lithotripsy is an adequate and safe alternative for the treatment of this condition.

Conditions

Interventions

TypeNameDescription
PROCEDURESingle-operator cholangioscopy guided electrohydraulic lithotripsySingle-operator cholangioscopy guided electrohydraulic lithotripsy has the advantage of providing direct visualization of the bile ducts, enabling a single physician to diagnose and perform the therapeutic intervention in a single procedure.

Timeline

Start date
2020-11-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2020-12-17
Last updated
2020-12-17

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04672902. Inclusion in this directory is not an endorsement.

Treatment of Mirizzi Syndrome (NCT04672902) · Clinical Trials Directory